Tu1301 Validation of a Homogenous Mobility Shift Assay (HMSA) for the Measurement of Vedolizumab (VLM) and Anti-VLM Antibodies in Inflammatory Bowel Disease (IBD) Patient Serum

Autor:	Stefan Westin, Rukmini Reddy, Nisha Donthi, Sharat Singh, Anjali Jain, Jared Salbato
Rok vydání:	2015
Předmět:	Hepatology biology business.industry Gastroenterology medicine.disease Inflammatory bowel disease Vedolizumab Immunology medicine biology.protein Electrophoretic mobility shift assay Antibody business medicine.drug
Zdroj:	Gastroenterology. 148:S-852
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(15)32889-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6ddf94f8dc12bc868d3938eb2767be88 https://doi.org/10.1016/s0016-5085(15)32889-4 Zobrazit plný text záznamu